Acura Pharmaceuticals Inc (ACUR) financial statements (2022 and earlier)

Company profile

Business Address 616 N. NORTH COURT, SUITE 120
PALATINE, IL 60067
State of Incorp. NY
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments   912,2202,68113,285
Cash and cash equivalents   912,2202,6812,485
Short-term investments      10,800
Restricted cash and investments     2,500 
Receivables  3467 (7)(91)
Inventory, net of allowances, customer advances and progress billings     309276
Inventory     309276
Other undisclosed current assets 1,1791,144303346427665
Total current assets: 1,1791,1784612,5665,91014,135
Noncurrent Assets
Nontrade receivables  3468135  
Property, plant and equipment 4845406066798671,013
Intangible assets, net (including goodwill) 738101,0171,2241,4311,638
Intangible assets, net (excluding goodwill) 738101,0171,2241,4311,638
Other undisclosed noncurrent assets      175
Total noncurrent assets: 5571,3841,6912,0382,2982,826
TOTAL ASSETS: 1,7362,5622,1524,6048,20816,961
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 6628221,2011,642780674
Accounts payable 31237605377110
Accrued liabilities 631585596939703564
Interest and dividends payable    700  
Debt 6,164  2,6942,3762,320
Other liabilities 182911412745
Other undisclosed current liabilities 678223223254304205
Total current liabilities: 7,5221,0741,4354,6313,4873,244
Noncurrent Liabilities
Long-term debt and lease obligation  6,000  2,9795,430
Long-term debt, excluding current maturities  6,000  2,9795,430
Liabilities, other than long-term debt   4,224   
Due to related parties   4,224   
Other undisclosed noncurrent liabilities 105229110 559387
Total noncurrent liabilities: 1056,2294,334 3,5385,817
Total liabilities: 7,6277,3035,7694,6317,0259,061
Stockholders' equity
Stockholders' equity attributable to parent (5,891)(4,741)(3,617)(27)1,1837,900
Common stock 216213210208118118
Additional paid in capital 383,097383,042380,395380,145375,763375,157
Accumulated other comprehensive loss      (65)
Accumulated deficit (389,204)(387,996)(384,222)(380,380)(374,698)(367,310)
Total stockholders' equity: (5,891)(4,741)(3,617)(27)1,1837,900
TOTAL LIABILITIES AND EQUITY: 1,7362,5622,1524,6048,20816,961

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 3,5702,6574102,9664,4648,587
Revenue, net2,9664,4646,087
Cost of revenue    (43)(56)(642)
Cost of goods and services sold     (26)(330)
Gross profit: 3,5702,6574102,9234,4087,945
Operating expenses (4,328)(3,590)(4,325)(8,148)(10,965)(11,946)
Other undisclosed operating income  208    
Operating loss: (758)(725)(3,915)(5,225)(6,557)(4,001)
Nonoperating income (expense)   73(592)(831)(988)
Investment income, nonoperating    460166
Interest and debt expense (450)(3,049)296(596)(893)(1,157)
Other undisclosed income from continuing operations before equity method investments, income taxes      1,157
Loss from continuing operations before equity method investments, income taxes: (1,208)(3,774)(3,546)(6,413)(8,281)(4,989)
Other undisclosed income (loss) from continuing operations before income taxes   (296)596893 
Loss from continuing operations before income taxes: (1,208)(3,774)(3,842)(5,817)(7,388)(4,989)
Income tax benefit    135  
Net loss available to common stockholders, diluted: (1,208)(3,774)(3,842)(5,682)(7,388)(4,989)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (1,208)(3,774)(3,842)(5,682)(7,388)(4,989)
Other comprehensive loss      (52)
Comprehensive loss: (1,208)(3,774)(3,842)(5,682)(7,388)(5,041)
Other undisclosed comprehensive income, net of tax, attributable to parent     65 
Comprehensive loss, net of tax, attributable to parent: (1,208)(3,774)(3,842)(5,682)(7,323)(5,041)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: